Pegfilgrastim biosimilar (Intas Biopharmaceuticals)

培非格司亭生物类似药 (Intas Biopharmaceuticals)

Report date: 2026/05/13 20:02:10

Base Information

Drug NamePegfilgrastim biosimilar (Intas Biopharmaceuticals)
Drug Alias Name非格司亭生物仿制药 (Intas Biopharmaceuticals)Recombinant pegylated granulocyte colony stimulating factor (Intas Biopharmaceuticals)聚乙二醇非格司亭生物仿制药 (Intas Biopharmaceuticals)PegastaNeupeg +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsAcute Radiation SyndromeFebrile NeutropeniaNeutropenia +[4] 
Global Approved IndicationsAcute Radiation SyndromeNeutropeniaNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2018/09/21
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesApotexIntas Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesLawson Health Research InstituteAccord Healthcare SluAccord Biopharma Inc
Inactive CompaniesN/A
Active IndicationsAcute Radiation SyndromeFebrile NeutropeniaNeutropenia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A